ArticleInternational journal of molecular sciences2022

Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy.

Yuhong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.